AGL 38.02 Increased By ▲ 0.08 (0.21%)
AIRLINK 197.36 Increased By ▲ 3.45 (1.78%)
BOP 9.54 Increased By ▲ 0.22 (2.36%)
CNERGY 5.91 Increased By ▲ 0.07 (1.2%)
DCL 8.82 Increased By ▲ 0.14 (1.61%)
DFML 35.74 Decreased By ▼ -0.72 (-1.97%)
DGKC 96.86 Increased By ▲ 4.32 (4.67%)
FCCL 35.25 Increased By ▲ 1.28 (3.77%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.17 Increased By ▲ 0.42 (3.29%)
HUBC 127.55 Increased By ▲ 6.94 (5.75%)
HUMNL 13.50 Decreased By ▼ -0.10 (-0.74%)
KEL 5.32 Increased By ▲ 0.10 (1.92%)
KOSM 7.00 Increased By ▲ 0.48 (7.36%)
MLCF 44.70 Increased By ▲ 2.59 (6.15%)
NBP 61.42 Increased By ▲ 1.61 (2.69%)
OGDC 214.67 Increased By ▲ 3.50 (1.66%)
PAEL 38.79 Increased By ▲ 1.21 (3.22%)
PIBTL 8.25 Increased By ▲ 0.18 (2.23%)
PPL 193.08 Increased By ▲ 2.76 (1.45%)
PRL 38.66 Increased By ▲ 0.49 (1.28%)
PTC 25.80 Increased By ▲ 2.35 (10.02%)
SEARL 103.60 Increased By ▲ 5.66 (5.78%)
TELE 8.30 Increased By ▲ 0.08 (0.97%)
TOMCL 35.00 Decreased By ▼ -0.03 (-0.09%)
TPLP 13.30 Decreased By ▼ -0.25 (-1.85%)
TREET 22.16 Decreased By ▼ -0.57 (-2.51%)
TRG 55.59 Increased By ▲ 2.72 (5.14%)
UNITY 32.97 Increased By ▲ 0.01 (0.03%)
WTL 1.60 Increased By ▲ 0.08 (5.26%)
BR100 11,727 Increased By 342.7 (3.01%)
BR30 36,377 Increased By 1165.1 (3.31%)
KSE100 109,513 Increased By 3238.2 (3.05%)
KSE30 34,513 Increased By 1160.1 (3.48%)

Although they are sometimes used to make spicy meals go down easier, common heartburn drugs can cause serious side effects and should be used with caution, a series of studies released on May 10 suggests. Well-known brands of the drugs - called proton pump inhibitors or PPIs - include AstraZeneca's Nexium and Prilosec.
Formerly AstraZeneca's biggest seller, Prilosec is available generically as omeprazole and is also sold over the counter by Procter & Gamble Co. While the drugs are a great help to the right patients, they can raise the risk of fractures in post-menopausal women and cause bacterial infections in many patients, according to a special report in the Archives of Internal Medicine.
Each year in the United States, patients fill an estimated 113 million prescriptions for PPIs, which treat inflammation of the esophagus, gastroesophageal reflux disease, ulcers and several other conditions.
The drugs have US sales of $13.9 billion a year, making them the third-biggest seller, according to Dr Mitchell Katz of the San Francisco Department of Public Health, who wrote a commentary in the same journal. Katz said the drugs are often used to treat common indigestion.
"That proton pump inhibitors relieve dyspepsia is without question, but at what cost (and I do not mean financial)?" he wrote. Katz said all drugs have side effects and sometimes the benefits outweigh the risks. But doctors need to keep that equation in mind, he wrote. In one of five studies in the report, a team led by Shelly Gray of the University of Washington in Seattle studied 161,806 women between 50 and 79. After eight years of follow-up, they found women who took the drugs were at greater risk for fractures overall, especially of the spine and wrist.
In a different study, Dr Michael Howell of Beth Israel Deaconess Medical Center and Harvard Medical School and colleagues analysed more than 100,000 patients discharged from hospitals over a five-year period. They found a 74 percent increase in cases of infections with Clostridium difficile - a common and sometimes deadly cause of diarrhea - among people who used a PPI daily.

Copyright Reuters, 2010

Comments

Comments are closed.